Ibiden Co Ltd
TSE:4062

Watchlist Manager
Ibiden Co Ltd Logo
Ibiden Co Ltd
TSE:4062
Watchlist
Price: 4 888 JPY 2.62% Market Closed
Market Cap: 683B JPY
Have any thoughts about
Ibiden Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Ibiden Co Ltd

Current Assets 539.3B
Cash & Short-Term Investments 374.2B
Receivables 60.3B
Other Current Assets 104.7B
Non-Current Assets 560.7B
Long-Term Investments 90.7B
PP&E 460.1B
Intangibles 4.4B
Other Non-Current Assets 5.6B
Current Liabilities 319.1B
Accounts Payable 42.4B
Accrued Liabilities 5.3B
Other Current Liabilities 271.5B
Non-Current Liabilities 290.5B
Long-Term Debt 273.3B
Other Non-Current Liabilities 17.2B

Balance Sheet
Ibiden Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
106 646
104 765
104 181
117 760
113 492
175 151
126 884
185 592
302 419
443 583
Cash Equivalents
106 646
104 765
104 181
117 760
113 492
175 151
126 884
185 592
302 419
443 583
Short-Term Investments
0
3 199
0
0
0
0
0
0
0
0
Total Receivables
59 308
57 288
56 357
62 134
60 180
68 877
89 687
91 989
79 446
65 330
Accounts Receivables
59 308
57 288
56 357
62 134
60 180
68 877
89 687
86 974
77 518
63 417
Other Receivables
0
0
0
0
0
0
0
5 015
1 928
1 913
Inventory
38 004
37 103
33 636
40 011
48 769
45 279
57 023
74 566
79 194
65 318
Other Current Assets
12 617
11 257
9 996
6 430
6 531
10 937
11 770
11 123
15 766
26 579
Total Current Assets
221 772
213 612
204 170
226 335
228 972
300 244
285 364
363 270
476 825
600 810
PP&E Net
236 153
215 928
151 152
151 308
146 710
173 514
214 828
225 920
306 967
408 777
Intangible Assets
6 870
5 168
4 213
3 689
4 162
4 486
5 392
5 448
5 179
4 590
Note Receivable
31
39
30
11
9
8
8
8
8
7
Long-Term Investments
52 287
39 060
44 106
51 954
39 142
34 461
68 198
64 638
61 342
110 166
Other Long-Term Assets
2 734
2 303
2 112
3 128
4 061
5 906
4 728
5 048
7 187
5 641
Total Assets
519 847
N/A
476 110
-8%
405 783
-15%
436 425
+8%
423 056
-3%
518 619
+23%
578 518
+12%
664 332
+15%
857 508
+29%
1 129 991
+32%
Liabilities
Accounts Payable
33 265
34 668
31 393
39 124
39 562
45 555
45 717
51 150
40 431
43 875
Accrued Liabilities
4 125
3 576
3 342
3 918
3 527
4 038
4 957
5 557
5 324
4 993
Short-Term Debt
22 600
20 000
20 000
20 000
20 030
20 030
20 130
20 030
20 030
20 000
Current Portion of Long-Term Debt
3 065
25 065
56
5
25 141
10 267
15 394
20 134
45 093
70 127
Other Current Liabilities
35 111
30 434
33 758
30 433
29 822
40 846
45 701
59 289
112 443
219 367
Total Current Liabilities
98 166
113 743
88 549
93 480
118 082
120 736
131 899
156 160
223 321
358 362
Long-Term Debt
50 547
25 163
50 091
50 078
25 043
120 038
115 216
130 199
205 167
253 606
Deferred Income Tax
8 968
3 751
4 377
4 574
2 042
1 712
7 185
5 163
893
13 501
Minority Interest
3 991
4 187
4 424
5 169
5 442
5 615
5 949
6 152
6 367
6 852
Other Liabilities
2 075
1 933
1 826
1 926
1 584
2 199
2 355
2 082
2 521
2 726
Total Liabilities
163 747
N/A
148 777
-9%
149 267
+0%
155 227
+4%
152 193
-2%
250 300
+64%
262 604
+5%
299 756
+14%
438 269
+46%
635 047
+45%
Equity
Common Stock
64 152
64 152
64 152
64 152
64 152
64 152
64 152
64 152
64 152
64 152
Retained Earnings
210 423
188 598
121 091
123 735
122 144
128 578
149 379
184 612
229 804
255 698
Additional Paid In Capital
68 354
64 579
64 579
64 579
64 579
64 579
64 433
64 494
64 494
64 494
Unrealized Security Profit/Loss
21 159
12 637
16 147
20 407
12 575
9 392
28 798
26 786
24 590
58 817
Treasury Stock
37 115
18 302
18 305
2 609
2 602
2 575
3 286
3 264
3 126
2 983
Other Equity
29 127
15 669
8 852
10 934
10 015
4 193
12 438
27 796
39 325
54 766
Total Equity
356 100
N/A
327 333
-8%
256 516
-22%
281 198
+10%
270 863
-4%
268 319
-1%
315 914
+18%
364 576
+15%
419 239
+15%
494 944
+18%
Total Liabilities & Equity
519 847
N/A
476 110
-8%
405 783
-15%
436 425
+8%
423 056
-3%
518 619
+23%
578 518
+12%
664 332
+15%
857 508
+29%
1 129 991
+32%
Shares Outstanding
Common Shares Outstanding
138
133
133
140
140
140
140
140
140
140

See Also

Discover More